Hongwei Shi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Oxidative Stress

Top Venues

Oxidative medicine and cellular longevity

BioMed research international

Current computer-aided drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Hanping He, Feng Yuan, Ying Li, Guoliang Pi, Hongwei Shi, Yanping Li, Guang Han
Comprehensive Analysis and Experimental Validation of FOXD2 as a Novel Potential Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Current computer-aided drug design (2024)
Hongwei Shi, Liang Duan, Ying Lan, Quan He, Peng Pu, Heng Tang
RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis. Oxidative medicine and cellular longevity 2023 (2023)
Hongwei Shi, Liang Duan, Ying Lan, Quan He, Peng Pu, Heng Tang
RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis. Oxidative medicine and cellular longevity 2023 (2023)
Hongwei Shi, Liang Duan, Ying Lan, Quan He, Peng Pu, Heng Tang
RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis. Oxidative medicine and cellular longevity 2023 (2023)
Hongwei Shi, Yue Yan, Hong Yang, Peng Pu, Heng Tang
Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin-Induced Hepatotoxicity. BioMed research international 2022 (2022)